BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Avidity Biosciences Honors Rare Disease Day® and Global Efforts to Support People and Families Impacted by Rare Neuromuscular Diseases

  March 3, 2025

   · 

  4 min read
• Press Releases

  Sarepta Therapeutics Announces Call for Applications for the 8th Annual Route 79, The Duchenne Scholarship Program

  March 3, 2025

   · 

  3 min read
• Press Releases

  Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 28, 2025

  March 3, 2025

   · 

  2 min read
• Press Releases

  Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

  March 3, 2025

   · 

  19 min read
• Press Releases

  BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines

  March 3, 2025

   · 

  14 min read
• Press Releases

  Outlook Therapeutics® Re-Submits Biologics License Application for ONS-5010 as a Treatment for Wet AMD to the U.S. Food and Drug Administration

  March 3, 2025

   · 

  7 min read
• Press Releases

  CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

  March 3, 2025

   · 

  10 min read
• Press Releases

  Daxor Expands Blood Volume Analysis Services at Major Midwest Healthcare Center

  March 3, 2025

   · 

  3 min read
• Press Releases

  Johnson & Johnson’s DARZALEX® (daratumumab) subcutaneous-based regimen receives positive CHMP opinion for patients with newly diagnosed multiple myeloma, regardless of transplant eligibility

  March 3, 2025

   · 

  13 min read
• Press Releases

  Praxis Precision Medicines Provides Update on Essential3 and Corporate Update

  March 3, 2025

   · 

  14 min read